Navigation Links
Research and Markets - Global Cervical Cancer Diagnostic Testing Market Growth of 6%, 2016-2020 with Becton, Hologic & Qiagen Dominating
Date:12/16/2016

DUBLIN, Dec 16, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Cervical Cancer Diagnostic Testing Market 2016-2020" report to their offering.

The report forecasts the global cervical cancer diagnostic testing market to grow at a CAGR of 6.90% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global cervical cancer diagnostic testing market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cervical cancer testing products used to perform cervical cancer screening.

According to the report, one driver in the market is reimbursement policies. Most of the developed countries have specific agencies that have reimbursement policies to motivate and support women to undergo diagnostic tests. Agencies such as Wittenberg Weiner Consulting (WWC) and Wisconsin Well Women Program (WWWP) in the US reimburse an office visit for a pelvic exam, Pap smear test, HPV test, colposcopy, or other invasive diagnostic procedures, case management, and administrative fees.

Similarly, diagnostic clinics have also started including cervical cancer diagnostics tests in their reimbursement policies. For Instance, Roche's cobas HPV Test is covered by Selah Genomics in its own certified laboratory. These favorable reimbursements coupled with the government initiatives will drive the cervical cancer diagnostic testing market during the forecast period.

Further, the report states that one challenge in the market is rising awareness toward cervical cancer over-screening. The medical authorities worldwide suggest that HPV test should replace current Pap smear test as the primary cervical cancer screening. Till now, most of the governments in the developed countries recommended women, to undergo Pap smear test once in every two years. With the adoption of the HPV testing, which suggests women undergo the test once in every five years, not only the over-screening will be reduced, but also the governments can save on overall healthcare budgets. Based on Roche's Athena clinical trial, the FDA acknowledged their cobas HPV test and recommended HPV testing as a replacement to Pap smear test.

Key vendors:

  • Abbott Molecular
  • Becton
  • Dickinson & Company
  • Hologic
  • Qiagen
  • Quest Diagnostics
  • Roche Molecular Diagnostics

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by test type

Part 07: Market segmentation by technology

Part 08: Market segmentation by method

Part 09: Market segmentation by end-user

Part 10: Geographical segmentation

Part 11: Buying criteria

Part 12: Market drivers

Part 13: Impact of drivers

Part 14: Market challenges

Part 15: Impact of drivers and challenges

Part 16: Market trends

Part 17: Vendor landscape

Part 18: Key vendor analysis

Part 19: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/vj6zzz/global_cervical

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-cervical-cancer-diagnostic-testing-market-growth-of-6-2016-2020-with-becton-hologic--qiagen-dominating-300379734.html


'/>"/>
SOURCE Research and Markets
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021 -- Research and Markets
2. Research and Markets - Global Dermatology Devices Market Analysis, 2016-2020 with Ge Healthcare, Syneron Medical & Agilent Technologies Dominating
3. Global Urology Devices Market Analysis 2016 - Forecast to 2022 - Drivers, Restraints, Opportunities, Threats, Challenges & Opportunities - Research and Markets
4. Research and Markets - Global Dental Implants Market Analysis 2016 - Forecast to 2022 - Key Vendors are Straumann AG, Nobel Biocare & 3M Company
5. Global Neurodiagnostic and Monitoring Devices Market - Increasing Incidence of Neurological Disorders - Research and Markets
6. Global Biosurgery Market to Reach $27 Billion by 2021 - Rising Need of Effective Blood Loss Management - Research and Markets
7. Global High Throughput Screening (Label-Free Technology, Cell-Based Assay, and Others) Strategic Business Report 2015-2022 - Research and Markets
8. Research and Markets - Global Optical Transceiver Market Growth at 16% CAGR by 2020 with Corning, Finisar & Reflex Photonics Dominating
9. Research and Markets - High-Throughput Screening (HTS) Market to Reach $18 Billion by 2021 With Axxam, Perkinelmer & Tecan Group Dominating
10. Research and Markets - Global Travel Vaccines Market 2016-2020: Market Growth at CAGR of 6.83% - Growing Demand Among Travelers / Additional Age Group Approval / Inclusion in NIP
11. Endodontic Supplies - Global Strategic Business Report - Research and Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):